| Comparative study of the PD-L1 status between surgically resected specimens and matched biopsies of NSCLC patients reveal major discordances: a potential issue for anti-PD-L1 … M Ilie, E Long-Mira, C Bence, C Butori, S Lassalle, L Bouhlel, L Fazzalari, ... Annals of Oncology 27 (1), 147-153, 2016 | 589 | 2016 |
| Candidate mechanisms for capecitabine‐related hand–foot syndrome G Milano, MC Etienne‐Grimaldi, M Mari, S Lassalle, JL Formento, ... British journal of clinical pharmacology 66 (1), 88-95, 2008 | 152 | 2008 |
| Multiplexed immunohistochemistry for molecular and immune profiling in lung cancer—just about ready for prime-time? P Hofman, C Badoual, F Henderson, L Berland, M Hamila, E Long-Mira, ... Cancers 11 (3), 283, 2019 | 126 | 2019 |
| Sarcomatoid lung cancer (spindle/giant cells): an aggressive disease? N Venissac, D Pop, S Lassalle, F Berthier, P Hofman, J Mouroux The Journal of thoracic and cardiovascular surgery 134 (3), 619-623, 2007 | 106 | 2007 |
| MiR-129-5p is required for histone deacetylase inhibitor-induced cell death in thyroid cancer cells O Bordone, VG Tanga, C Bonnetaud, C Moreilhon, G Rios, J Santini, ... Endocrine-related cancer 18, 711-719, 2011 | 99 | 2011 |
| Current views on tumor mutational burden in patients with non-small cell lung cancer treated by immune checkpoint inhibitors L Berland, S Heeke, O Humbert, A Macocco, E Long-Mira, S Lassalle, ... Journal of thoracic disease 11 (Suppl 1), S71, 2019 | 87 | 2019 |
| Differential expression and regulation of ADAM17 and TIMP3 in acute inflamed intestinal epithelia A Cesaro, A Abakar-Mahamat, P Brest, S Lassalle, E Selva, J Filippi, ... American Journal of Physiology-Gastrointestinal and Liver Physiology 296 (6 …, 2009 | 84 | 2009 |
| Gene expression profiling in human gastric mucosa infected with Helicobacter pylori VJ Hofman, C Moreilhon, PD Brest, S Lassalle, K Le Brigand, D Sicard, ... Modern Pathology 20 (9), 974-989, 2007 | 80 | 2007 |
| Thyroid tumours of uncertain malignant potential: frequency and diagnostic reproducibility V Hofman, S Lassalle, C Bonnetaud, C Butori, C Loubatier, M Ilie, ... Virchows Archiv 455, 21-33, 2009 | 77 | 2009 |
| Single-cell RNA sequencing reveals intratumoral heterogeneity in primary uveal melanomas and identifies HES6 as a driver of the metastatic disease C Pandiani, T Strub, N Nottet, Y Cheli, G Gambi, K Bille, C Husser, ... Cell Death & Differentiation 28 (6), 1990-2000, 2021 | 76 | 2021 |
| The thyroid gland: a crossroad in inflammation-induced carcinoma? An ongoing debate with new therapeutic potential. A Bozec, S Lassalle, V Hofman, M Ilie, J Santini, P Hofman Current medicinal chemistry 17 (30), 3449-3461, 2010 | 73 | 2010 |
| Dual inhibition of EGFR and VEGFR pathways in combination with irradiation: antitumour supra-additive effects on human head and neck cancer xenografts A Bozec, P Formento, S Lassalle, C Lippens, P Hofman, G Milano British journal of cancer 97 (1), 65-72, 2007 | 73 | 2007 |
| Diagnostic Value of Immunohistochemistry for the Detection of the BRAFV600E Mutation in Papillary Thyroid Carcinoma: Comparative Analysis with Three DNA … MI Ilie, S Lassalle, E Long-Mira, C Bonnetaud, O Bordone, V Lespinet, ... Thyroid 24 (5), 858-866, 2014 | 72 | 2014 |
| Assessment of morphology, antigenicity, and nucleic acid integrity for diagnostic thyroid pathology using formalin substitute fixatives S Lassalle, V Hofman, M Ilie, V Gavric-Tanga, P Brest, K Havet, C Butori, ... Thyroid 19 (11), 1239-1248, 2009 | 62 | 2009 |
| Optimization of EGFR mutation detection by the fully-automated qPCR-based Idylla system on tumor tissue from patients with non-small cell lung cancer M Ilie, C Butori, S Lassalle, S Heeke, N Piton, JC Sabourin, V Tanga, ... Oncotarget 8 (61), 103055, 2017 | 58 | 2017 |
| Clinical impact of the detection of BRAF mutations in thyroid pathology: potential usefulness as diagnostic, prognostic and theragnostic applications S Lassalle, V Hofman, M Ilie, C Butori, A Bozec, J Santini, P Vielh, ... Current medicinal chemistry 17 (17), 1839-1850, 2010 | 51 | 2010 |
| MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib S Lassalle, J Zangari, A Popa, M Ilie, V Hofman, E Long, M Patey, ... Oncotarget 7 (21), 30461, 2016 | 50 | 2016 |
| Prognostic biomarkers in uveal melanoma: The status quo, recent advances and future directions NJ Lamas, A Martel, S Nahon-Estève, S Goffinet, A Macocco, C Bertolotto, ... Cancers 14 (1), 96, 2021 | 47 | 2021 |
| Involvement of mast cells in gastritis caused by Helicobacter pylori: a potential role in epithelial cell apoptosis V Hofman, S Lassalle, E Selva, K Kalem, A Steff, X Hébuterne, D Sicard, ... Journal of clinical pathology 60 (6), 600-607, 2007 | 46 | 2007 |
| Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland? S Lassalle, V Hofman, M Ilie, C Bonnetaud, MP Puisségur, P Brest, ... Endocrine-related cancer 18 (5), 579-594, 2011 | 45 | 2011 |
